CN Patent

CN112125929A — 用于偶联的亲水链接体

Assigned to Hangzhou Dac Biotech Co Ltd · Expires 2020-12-25 · 5y expired

What this patent protects

本专利申请提供包含亲水链接体的细胞结合分子‑药物偶联物，以及使用这些链接体和偶联物的方法。

USPTO Abstract

本专利申请提供包含亲水链接体的细胞结合分子‑药物偶联物，以及使用这些链接体和偶联物的方法。

Drugs covered by this patent

naloxegol-oxalate (NALOXEGOL OXALATE)

Patent Metadata

Patent number: CN112125929A
Jurisdiction: CN
Classification: —
Expires: 2020-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Hangzhou Dac Biotech Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.